Literature DB >> 10857984

Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.

A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley, F L Brancati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10857984     DOI： 10.2337/diacare.23.1.126a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

Review 1.  PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.

Authors:  Simona Cataldi; Valerio Costa; Alfredo Ciccodicola; Marianna Aprile
Journal:  Curr Diab Rep       Date:  2021-04-18       Impact factor: 4.810

Review 2.  The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.

Authors:  Francesco S Celi; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 3.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

4.  Rare mutations of peroxisome proliferator-activated receptor gamma: frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa.

Authors:  Z Vergotine; A P Kengne; R T Erasmus; Y Y Yako; T E Matsha
Journal:  Int J Endocrinol       Date:  2014-08-14       Impact factor: 3.257
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.